Monsanto Co. (NYSE:MON) Receives Average Recommendation of “Buy” from Analysts
Shares of Monsanto Co. (NYSE:MON) have received a consensus recommendation of “Buy” from the twenty-seven brokerages that are covering the firm. Two equities research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation, fifteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $112.97.
A number of brokerages recently commented on MON. Monness Crespi & Hardt reduced their price objective on shares of Monsanto from $130.00 to $128.00 and set a “buy” rating for the company in a research note on Monday. Goldman Sachs Group Inc. raised shares of Monsanto from a “sell” rating to a “neutral” rating and set a $104.00 price objective for the company in a research note on Tuesday, September 27th. Sanford C. Bernstein raised shares of Monsanto from an “underperform” rating to a “market perform” rating and boosted their price objective for the stock from $82.81 to $105.00 in a research note on Monday, September 26th. JPMorgan Chase & Co. raised shares of Monsanto from a “neutral” rating to an “overweight” rating and set a $128.00 price objective for the company in a research note on Wednesday, September 21st. Finally, Piper Jaffray Cos. set a $128.00 price objective on shares of Monsanto and gave the stock a “buy” rating in a research note on Thursday, September 15th.
Monsanto (NYSE:MON) traded up 0.930% during trading on Wednesday, hitting $102.555. The stock had a trading volume of 2,626,345 shares. Monsanto has a 52-week low of $83.73 and a 52-week high of $114.26. The firm has a market cap of $44.88 billion, a PE ratio of 45.139 and a beta of 1.19. The company’s 50 day moving average is $104.97 and its 200 day moving average is $101.31.
Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. Monsanto’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.19) earnings per share. Equities research analysts forecast that Monsanto will post $4.46 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio is presently 89.26%.
In other Monsanto news, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction dated Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the sale, the chief operating officer now owns 102,480 shares in the company, valued at approximately $10,618,977.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction dated Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in the stock. BNP Paribas Arbitrage SA increased its stake in Monsanto by 5.2% in the third quarter. BNP Paribas Arbitrage SA now owns 308,850 shares of the company’s stock worth $31,564,000 after buying an additional 15,128 shares during the last quarter. Beacon Financial Group increased its stake in Monsanto by 93.9% in the third quarter. Beacon Financial Group now owns 26,832 shares of the company’s stock worth $2,731,000 after buying an additional 12,993 shares during the last quarter. Macquarie Group Ltd. increased its stake in Monsanto by 49.2% in the second quarter. Macquarie Group Ltd. now owns 53,664 shares of the company’s stock worth $5,550,000 after buying an additional 17,692 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in Monsanto during the second quarter worth approximately $1,824,000. Finally, Kentucky Retirement Systems acquired a new stake in Monsanto during the second quarter worth approximately $3,841,000. Institutional investors own 79.02% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.